Nancy S Chiles1, Caroline L Phillips2, Stefano Volpato3, Stefania Bandinelli4, Luigi Ferrucci5, Jack M Guralnik6, Kushang V Patel7. 1. Doctoral Program in Gerontology, University of Maryland Baltimore and Baltimore County, 660 West Redwood Street, Suite 200, Baltimore, MD 21201-1596, USA; Department of Epidemiology and Public Health, University of Maryland Baltimore, 660 W. Redwood St, Suite 200, Baltimore, MD 21201-1596, USA. Electronic address: nchiles@epi.umaryland.edu. 2. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Gateway Building Suite 3C309, Bethesda, MD 20892-9205, USA. 3. Department of Medical Sciences, University of Ferrara, Ferrara, Italy. 4. Geriatric Rehabilitation Unit, Azienda Sanitaria di Firenze, Florence, Italy. 5. Longitudinal Studies Section, Clinical Research Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA. 6. Department of Epidemiology and Public Health, University of Maryland Baltimore, 660 W. Redwood St, Suite 200, Baltimore, MD 21201-1596, USA. 7. Department of Anesthesiology and Pain Medicine, University of Washington, Box 356540, 1959 NE Pacific Street, BB-1469, Seattle, WA 98195-6540, USA.
Abstract
OBJECTIVE: Diabetes among older adults causes many complications, including decreased lower-extremity function and physical disability. Diabetes can cause peripheral nerve dysfunction, which might be one pathway through which diabetes leads to decreased physical function. The study aims were to determine the following: (1) whether diabetes and impaired fasting glucose are associated with objective measures of physical function in older adults, (2) which peripheral nerve function (PNF) tests are associated with diabetes, and (3) whether PNF mediates the diabetes-physical function relationship. RESEARCH DESIGN AND METHODS: This study included 983 participants, age 65 years and older from the InCHIANTI study. Diabetes was diagnosed by clinical guidelines. Physical performance was assessed using the Short Physical Performance Battery (SPPB), scored from 0 to 12 (higher values, better physical function) and usual walking speed (m/s). PNF was assessed via standard surface electroneurographic study of right peroneal nerve conduction velocity, vibration and touch sensitivity. Clinical cutpoints of PNF tests were used to create a neuropathy score from 0 to 5 (higher values, greater neuropathy). Multiple linear regression models were used to test associations. RESULTS AND CONCLUSION: One hundred twenty-six (12.8%) participants had diabetes. Adjusting for age, sex, education, and other confounders, diabetic participants had decreased SPPB (β=-0.99; p<0.01), decreased walking speed (β=-0.1m/s; p<0.01), decreased nerve conduction velocity (β=-1.7m/s; p<0.01), and increased neuropathy (β=0.25; p<0.01) compared to non-diabetic participants. Adjusting for nerve conduction velocity and neuropathy score decreased the effect of diabetes on SPPB by 20%, suggesting partial mediation through decreased PNF.
OBJECTIVE:Diabetes among older adults causes many complications, including decreased lower-extremity function and physical disability. Diabetes can cause peripheral nerve dysfunction, which might be one pathway through which diabetes leads to decreased physical function. The study aims were to determine the following: (1) whether diabetes and impaired fasting glucose are associated with objective measures of physical function in older adults, (2) which peripheral nerve function (PNF) tests are associated with diabetes, and (3) whether PNF mediates the diabetes-physical function relationship. RESEARCH DESIGN AND METHODS: This study included 983 participants, age 65 years and older from the InCHIANTI study. Diabetes was diagnosed by clinical guidelines. Physical performance was assessed using the Short Physical Performance Battery (SPPB), scored from 0 to 12 (higher values, better physical function) and usual walking speed (m/s). PNF was assessed via standard surface electroneurographic study of right peroneal nerve conduction velocity, vibration and touch sensitivity. Clinical cutpoints of PNF tests were used to create a neuropathy score from 0 to 5 (higher values, greater neuropathy). Multiple linear regression models were used to test associations. RESULTS AND CONCLUSION: One hundred twenty-six (12.8%) participants had diabetes. Adjusting for age, sex, education, and other confounders, diabeticparticipants had decreased SPPB (β=-0.99; p<0.01), decreased walking speed (β=-0.1m/s; p<0.01), decreased nerve conduction velocity (β=-1.7m/s; p<0.01), and increased neuropathy (β=0.25; p<0.01) compared to non-diabeticparticipants. Adjusting for nerve conduction velocity and neuropathy score decreased the effect of diabetes on SPPB by 20%, suggesting partial mediation through decreased PNF.
Authors: J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace Journal: J Gerontol A Biol Sci Med Sci Date: 2000-04 Impact factor: 6.053
Authors: Seok Won Park; Bret H Goodpaster; Elsa S Strotmeyer; Nathalie de Rekeneire; Tamara B Harris; Ann V Schwartz; Frances A Tylavsky; Anne B Newman Journal: Diabetes Date: 2006-06 Impact factor: 9.461
Authors: Stefano Volpato; Caroline Blaum; Helaine Resnick; Luigi Ferrucci; Linda P Fried; Jack M Guralnik Journal: Diabetes Care Date: 2002-04 Impact factor: 19.112
Authors: L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik Journal: J Am Geriatr Soc Date: 2000-12 Impact factor: 5.562
Authors: Edward W Gregg; Paul Sorlie; Ryne Paulose-Ram; Qiuping Gu; Mark S Eberhardt; Michael Wolz; Vicki Burt; Lester Curtin; Michael Engelgau; Linda Geiss Journal: Diabetes Care Date: 2004-07 Impact factor: 19.112
Authors: Vijaya Kancherla; John L Elliott; Birju B Patel; N Wilson Holland; Theodore M Johnson; Anjali Khakharia; Lawrence S Phillips; Godfrey P Oakley; Camille P Vaughan Journal: J Am Geriatr Soc Date: 2017-02-09 Impact factor: 5.562
Authors: Rachel E Ward; Paolo Caserotti; Jane A Cauley; Robert M Boudreau; Bret H Goodpaster; Aaron I Vinik; Anne B Newman; Elsa S Strotmeyer Journal: Aging Dis Date: 2015-11-27 Impact factor: 6.745
Authors: Linda J D'Silva; Patricia M Kluding; Susan L Whitney; Hongying Dai; Marcio Santos Journal: Int J Neurosci Date: 2017-04-25 Impact factor: 2.292
Authors: Domenico Intiso; Mario Basciani; Andrea Santamato; Marta Intiso; Filomena Di Rienzo Journal: Toxins (Basel) Date: 2015-06-30 Impact factor: 4.546